| Schedule of Revenues by Geographic Region |
The Company’s net revenues by geographic region, based on the patient’s location are summarized as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | Year ended December 31, | | | 2024 | 0 | 2023 | | 2024 | | 2023 | | 2023 | | United States | $ | 95,711 | | | $ | 86,958 | | | $ | 186,254 | | | $ | 172,186 | | | $ | 349,743 | | | International markets: | | | | | | | | | | | Germany | 15,097 | | | 15,744 | | | 30,844 | | | 30,864 | | | 60,210 | | France (1) | 14,267 | | | — | | | 24,755 | | | — | | | 11,736 | | | Japan | 7,664 | | | 7,861 | | | 15,481 | | | 16,530 | | | 31,668 | | | Other international markets | 11,771 | | | 8,737 | | | 20,742 | | | 16,587 | | | 32,757 | | | International markets - Total | 48,799 | | | 32,342 | | | 91,822 | | | 63,981 | | | 136,371 | | | | | | | | | | | | Greater China (2) | 5,846 | | | 6,751 | | | 10,783 | | | 12,066 | | | 23,224 | | | | | | | | | | | | | Total net revenues | $ | 150,356 | | | $ | 126,051 | | | $ | 288,859 | | | $ | 248,233 | | | $ | 509,338 | |
(1) For periods ending prior to December 31, 2023, net revenue for France is included in "Other international markets". (2) For additional information, see Notes 12 and 13 to the Consolidated Financial Statements in the 2023 10-K.
|
| Revenue Recognized According Performance Period |
The Company's net revenues by performance period are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | Year ended December 31, | | | 2024 | 0 | 2023 | | 2024 | | 2023 | | 2023 | | Net revenues recognized in the reporting period from performance obligations satisfied in: | | | | | | | | | | | Reporting period | $ | 138,857 | | | $ | 119,823 | | | $ | 269,343 | | | $ | 236,932 | | | $ | 492,089 | | | Previous periods | 11,499 | | | 6,228 | | | 19,516 | | | 11,301 | | | 17,249 | | | Total net revenues | $ | 150,356 | | | $ | 126,051 | | | $ | 288,859 | | | $ | 248,233 | | | $ | 509,338 | |
|
| Contract with Customer, Contract Asset, Contract Liability, and Receivable |
The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers: | | | | | | | | | | | | | June 30, 2024 | | December 31, 2023 | | | Unaudited | | Audited | | Trade receivables | $ | 59,869 | | | $ | 56,970 | | | Unbilled receivables | $ | 4,834 | | | $ | 4,251 | | | Deferred revenues (short-term contract liabilities) | (15,605) | | | (16,224) | |
|